Business Information
The group's principal activities are developing, manufacturing and distributing pharmaceutical products in the field of gastroenterology. The major products of the group include amphojel, adeks, canasa, cortenema, endospray, flutter, lansoyl, modulon, mucaine, scandishake, salofalk, photofrin, viokase, ultrase and urso 250. The group also operates in United States, Europe and other foreign countries.
|
|
Name |
Title
|
Email
|
| Leon Gosselin | Chmn. | Available | | Alexandre Lebeaut | Chief Scientific Officer, Sr. VP | N/A | | Steve Gannon | Sr. VP, CFO | N/A | | Darcy Toms | VP - Business Development | N/A | | David Mims | COO, Exec. VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 292,317 | 39,119 | | 2005 | 251,343 | 26,425 | | 2004 | 243,634 | 48,728
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
